Immunochemistry Market in Americas 2024-2028

PUBLISHED: May 3, 2024

PAGES: 160 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

Global Immunochemistry Market In Americas 2024-2028

The immunochemistry market in americas is forecasted to grow by USD 3621.75 mn during 2023-2028, accelerating at a CAGR of 6.98% during the forecast period. The report on the immunochemistry market in americas provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, increasing incidences of neurological disorders, and technological advances in antibody manufacturing.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	6.42%
CAGR	6.98%
Incremental Value	$3621.75mn

Technavio's immunochemistry market in americas is segmented as below:

By Product

Consumables
Equipment

By Application

Infectious disease
Cardiology
Oncology
Autoimmune disease
Nephrology and others

By Geographical Landscape

Americas

This study identifies the rising new product launches as one of the prime reasons driving the immunochemistry market in americas growth during the next few years. Also, increasing number of clinical trials and emergence of new disease targets will lead to sizable demand in the market.

The report on the immunochemistry market in americas covers the following areas:

Immunochemistry market in americas sizing
Immunochemistry market in americas forecast
Immunochemistry market in americas industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunochemistry market in americas vendors that include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., bioMerieux SA, Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Grifols SA, Hologic Inc., Merck and Co. Inc., Mindray Bio medical Electronics Co. Ltd., PerkinElmer Inc., Quanterix Corp., Randox Laboratories Ltd., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Tosoh Corp.. Also, the immunochemistry market in americas analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR77896

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

4.1 Immunochemistry market in Americas 2018 - 2022
4.2 Product Segment Analysis 2018 - 2022
4.3 Application Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022

5 Five Forces Analysis

5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition

6 Market Segmentation by Product

6.1 Market segments
6.2 Comparison by Product
6.3 Consumables - Market size and forecast 2023-2028
6.4 Equipment - Market size and forecast 2023-2028
6.5 Market opportunity by Product

7 Market Segmentation by Application

7.1 Market segments
7.2 Comparison by Application
7.3 Infectious disease - Market size and forecast 2023-2028
7.4 Cardiology - Market size and forecast 2023-2028
7.5 Oncology - Market size and forecast 2023-2028
7.6 Autoimmune disease - Market size and forecast 2023-2028
7.7 Nephrology and others - Market size and forecast 2023-2028
7.8 Market opportunity by Application

8 Customer Landscape

8.1 Customer landscape overview

9 Geographic Landscape

9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 South America - Market size and forecast 2023-2028
9.5 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks

12 Vendor Analysis

12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Abbott Laboratories
12.4 Agilent Technologies Inc.
12.5 Becton Dickinson and Co.
12.6 Bio Rad Laboratories Inc.
12.7 Bio Techne Corp.
12.8 Danaher Corp.
12.9 DiaSorin SpA
12.10 F. Hoffmann La Roche Ltd.
12.11 Fujirebio Holdings Inc.
12.12 Merck and Co. Inc.
12.13 Quanterix Corp.
12.14 Randox Laboratories Ltd.
12.15 Siemens AG
12.16 Sysmex Corp.
12.17 Thermo Fisher Scientific Inc.

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations

Product Code: IRTNTR77896

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Americas - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Americas: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Exhibits18: Historic Market Size - Data Table on immunochemistry market in Americas 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Five forces analysis - Comparison between 2023 and 2028
Exhibits23: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits24: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits25: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits26: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits27: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits28: Chart on Market condition - Five forces 2023 and 2028
Exhibits29: Chart on Product - Market share 2023-2028 (%)
Exhibits30: Data Table on Product - Market share 2023-2028 (%)
Exhibits31: Chart on Comparison by Product
Exhibits32: Data Table on Comparison by Product
Exhibits33: Chart on Consumables - Market size and forecast 2023-2028 ($ million)
Exhibits34: Data Table on Consumables - Market size and forecast 2023-2028 ($ million)
Exhibits35: Chart on Consumables - Year-over-year growth 2023-2028 (%)
Exhibits36: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
Exhibits37: Chart on Equipment - Market size and forecast 2023-2028 ($ million)
Exhibits38: Data Table on Equipment - Market size and forecast 2023-2028 ($ million)
Exhibits39: Chart on Equipment - Year-over-year growth 2023-2028 (%)
Exhibits40: Data Table on Equipment - Year-over-year growth 2023-2028 (%)
Exhibits41: Market opportunity by Product ($ million)
Exhibits42: Data Table on Market opportunity by Product ($ million)
Exhibits43: Chart on Application - Market share 2023-2028 (%)
Exhibits44: Data Table on Application - Market share 2023-2028 (%)
Exhibits45: Chart on Comparison by Application
Exhibits46: Data Table on Comparison by Application
Exhibits47: Chart on Infectious disease - Market size and forecast 2023-2028 ($ million)
Exhibits48: Data Table on Infectious disease - Market size and forecast 2023-2028 ($ million)
Exhibits49: Chart on Infectious disease - Year-over-year growth 2023-2028 (%)
Exhibits50: Data Table on Infectious disease - Year-over-year growth 2023-2028 (%)
Exhibits51: Chart on Cardiology - Market size and forecast 2023-2028 ($ million)
Exhibits52: Data Table on Cardiology - Market size and forecast 2023-2028 ($ million)
Exhibits53: Chart on Cardiology - Year-over-year growth 2023-2028 (%)
Exhibits54: Data Table on Cardiology - Year-over-year growth 2023-2028 (%)
Exhibits55: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits56: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits57: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits58: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits59: Chart on Autoimmune disease - Market size and forecast 2023-2028 ($ million)
Exhibits60: Data Table on Autoimmune disease - Market size and forecast 2023-2028 ($ million)
Exhibits61: Chart on Autoimmune disease - Year-over-year growth 2023-2028 (%)
Exhibits62: Data Table on Autoimmune disease - Year-over-year growth 2023-2028 (%)
Exhibits63: Chart on Nephrology and others - Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on Nephrology and others - Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on Nephrology and others - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on Nephrology and others - Year-over-year growth 2023-2028 (%)
Exhibits67: Market opportunity by Application ($ million)
Exhibits68: Data Table on Market opportunity by Application ($ million)
Exhibits69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits70: Chart on Market share By Geographical Landscape - 2023-2028 (%)
Exhibits71: Data Table on Market share By Geographical Landscape - 2023-2028 (%)
Exhibits72: Chart on Geographic comparison
Exhibits73: Data Table on Geographic comparison
Exhibits74: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits75: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits76: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits77: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits78: Chart on South America - Market size and forecast 2023-2028 ($ million)
Exhibits79: Data Table on South America - Market size and forecast 2023-2028 ($ million)
Exhibits80: Chart on South America - Year-over-year growth 2023-2028 (%)
Exhibits81: Data Table on South America - Year-over-year growth 2023-2028 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Data Table on Market opportunity By Geographical Landscape ($ million)
Exhibits84: Impact of drivers and challenges in 2023 and 2028
Exhibits85: Overview on Criticality of inputs and Factors of differentiation
Exhibits86: Overview on factors of disruption
Exhibits87: Impact of key risks on business
Exhibits88: Vendors covered
Exhibits89: Matrix on vendor position and classification
Exhibits90: Abbott Laboratories - Overview
Exhibits91: Abbott Laboratories - Business segments
Exhibits92: Abbott Laboratories - Key news
Exhibits93: Abbott Laboratories - Key offerings
Exhibits94: Abbott Laboratories - Segment focus
Exhibits95: Agilent Technologies Inc. - Overview
Exhibits96: Agilent Technologies Inc. - Business segments
Exhibits97: Agilent Technologies Inc. - Key news
Exhibits98: Agilent Technologies Inc. - Key offerings
Exhibits99: Agilent Technologies Inc. - Segment focus
Exhibits100: Becton Dickinson and Co. - Overview
Exhibits101: Becton Dickinson and Co. - Business segments
Exhibits102: Becton Dickinson and Co. - Key offerings
Exhibits103: Becton Dickinson and Co. - Segment focus
Exhibits104: Bio Rad Laboratories Inc. - Overview
Exhibits105: Bio Rad Laboratories Inc. - Business segments
Exhibits106: Bio Rad Laboratories Inc. - Key news
Exhibits107: Bio Rad Laboratories Inc. - Key offerings
Exhibits108: Bio Rad Laboratories Inc. - Segment focus
Exhibits109: Bio Techne Corp. - Overview
Exhibits110: Bio Techne Corp. - Business segments
Exhibits111: Bio Techne Corp. - Key offerings
Exhibits112: Bio Techne Corp. - Segment focus
Exhibits113: Danaher Corp. - Overview
Exhibits114: Danaher Corp. - Business segments
Exhibits115: Danaher Corp. - Key news
Exhibits116: Danaher Corp. - Key offerings
Exhibits117: Danaher Corp. - Segment focus
Exhibits118: DiaSorin SpA - Overview
Exhibits119: DiaSorin SpA - Business segments
Exhibits120: DiaSorin SpA - Key offerings
Exhibits121: DiaSorin SpA - Segment focus
Exhibits122: F. Hoffmann La Roche Ltd. - Overview
Exhibits123: F. Hoffmann La Roche Ltd. - Business segments
Exhibits124: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits125: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits126: Fujirebio Holdings Inc. - Overview
Exhibits127: Fujirebio Holdings Inc. - Product / Service
Exhibits128: Fujirebio Holdings Inc. - Key offerings
Exhibits129: Merck and Co. Inc. - Overview
Exhibits130: Merck and Co. Inc. - Business segments
Exhibits131: Merck and Co. Inc. - Key news
Exhibits132: Merck and Co. Inc. - Key offerings
Exhibits133: Merck and Co. Inc. - Segment focus
Exhibits134: Quanterix Corp. - Overview
Exhibits135: Quanterix Corp. - Product / Service
Exhibits136: Quanterix Corp. - Key offerings
Exhibits137: Randox Laboratories Ltd. - Overview
Exhibits138: Randox Laboratories Ltd. - Key offerings
Exhibits139: Siemens AG - Overview
Exhibits140: Siemens AG - Business segments
Exhibits141: Siemens AG - Key news
Exhibits142: Siemens AG - Key offerings
Exhibits143: Siemens AG - Segment focus
Exhibits144: Sysmex Corp. - Overview
Exhibits145: Sysmex Corp. - Business segments
Exhibits146: Sysmex Corp. - Key offerings
Exhibits147: Sysmex Corp. - Segment focus
Exhibits148: Thermo Fisher Scientific Inc. - Overview
Exhibits149: Thermo Fisher Scientific Inc. - Business segments
Exhibits150: Thermo Fisher Scientific Inc. - Key news
Exhibits151: Thermo Fisher Scientific Inc. - Key offerings
Exhibits152: Thermo Fisher Scientific Inc. - Segment focus
Exhibits153: Inclusions checklist
Exhibits154: Exclusions checklist
Exhibits155: Currency conversion rates for US$
Exhibits156: Research methodology
Exhibits157: Validation techniques employed for market sizing
Exhibits158: Information sources
Exhibits159: List of abbreviations